Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > Webinar: Using E. coli To Identify Stability Liabilities in Therapeutic and Disease-Causing Proteins
  1. Webinar: Using E. coli To Identify Stability Liabilities in Therapeutic and Disease-Causing Proteins

    1. December 8, 2022
    2. Online
    3. ACROBiosystems and others
    Check more webinar details below.
    Click the button to enter our raffle.
  2. ACROBiosystems is proud to sponsor the webinar “Using E. coli To Identify Stability Liabilities in Therapeutic and Disease-Causing Proteins”!


    This webinar will be hosted live and available on-demand

    Thursday, December 8, 2022 | 8am PST | 11am EST

     

    Many years have passed since recombinant human insulin, the first medicine made via recombinant DNA technology, was approved by the FDA. The continuous rise in the approval of protein therapeutics demonstrates the potential that biopharmaceuticals have to become the medicines of the future.


    This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.

     

    Attend this webinar to:

    ·      Hear more about monoclonal antibodies and their impact

    ·      Discover incredible studies and recent developments in this field

    ·      Follow the development of a new assay used to investigate important proteins in biopharma

     

    Speaker Information:



New & Hot Products


This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message